Mo1953 Rising Incidence of Intestinal Infections in Inflammatory Bowel Diseases: A Nationwide Analysis

[1]  Nasia Safdar,et al.  Current Trends in the Epidemiology and Outcomes of Clostridium difficile Infection. , 2015, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[2]  V. Villanacci,et al.  Intestinal superinfections in patients with inflammatory bowel diseases. , 2012, Journal of Crohn's & colitis.

[3]  Fiona Powrie,et al.  Intestinal homeostasis and its breakdown in inflammatory bowel disease , 2011, Nature.

[4]  D. Pardi,et al.  The growing incidence and severity of Clostridium difficile infection in inpatient and outpatient settings , 2010, Expert review of gastroenterology & hepatology.

[5]  M. Abreu,et al.  Clinical Outcomes of Patients with Ulcerative Colitis and Co-existing Clostridium difficile Infection , 2010, Digestive Diseases and Sciences.

[6]  G. Kaplan,et al.  A National Survey of the Prevalence and Impact of Clostridium difficile Infection Among Hospitalized Inflammatory Bowel Disease Patients , 2008, The American Journal of Gastroenterology.

[7]  Dawn B. Beaulieu,et al.  Impact of Clostridium difficile on inflammatory bowel disease. , 2007, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[8]  Stuart Johnson,et al.  An epidemic, toxin gene-variant strain of Clostridium difficile. , 2005, The New England journal of medicine.

[9]  C. Sirio,et al.  Fulminant Clostridium difficile: An Underappreciated and Increasing Cause of Death and Complications , 2002, Annals of surgery.

[10]  R. Deyo,et al.  Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. , 1992, Journal of clinical epidemiology.

[11]  C. Mackenzie,et al.  A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. , 1987, Journal of chronic diseases.